Clinical trial results support strategy for reversing type 1 diabetes
13:00 EDT 8 Aug 2012 | Medical Xpress
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune system modulator can cause the death of autoimmune cells targeting the insulin-secreting cells of the pancreas and temporarily restore insulin secretion..
Original Article: Clinical trial results support strategy for reversing type 1 diabetes
More From BioPortfolio on "Clinical trial results support strategy for reversing type 1 diabetes"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
